Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Organon & Co. (NY: OGN ) 19.33 +0.16 (+0.83%) Streaming Delayed Price Updated: 11:46 AM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Organon & Co. < Previous 1 2 3 4 5 6 7 8 9 Next > Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy September 21, 2024 Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and... Via Talk Markets Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B September 18, 2024 Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including FDA-approved Vtama cream for plaque psoriasis. The deal, valued up to $1.2... Via Benzinga Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% September 18, 2024 From Organon & Co. Via Business Wire Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% September 18, 2024 From Roivant Sciences Via GlobeNewswire 3 Cheap High Dividend Stocks For Passive Income August 30, 2024 These undervalued high yield stocks could return over 10% per year. Via Talk Markets High Dividend 50: Organon & Co. June 27, 2024 Organon & Co.’s current annual dividend is $1.12 per share. At around $20 per share, Organon stock has a high yield of 5.4%. Via Talk Markets JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability September 06, 2024 JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris. Via Benzinga Organon Stock Sees Relative Strength Rating Rise To 91 August 27, 2024 On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before. Via Investor's Business Daily Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold August 20, 2024 On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier. Via Investor's Business Daily Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets August 20, 2024 From Organon & Co. Via Business Wire OGN Stock Earnings: Organon Beats EPS, Misses Revenue for Q2 2024 August 06, 2024 OGN stock results show that Organon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Organon Reports Results for the Second Quarter Ended June 30, 2024 August 06, 2024 From Organon & Co. Via Business Wire Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount' July 30, 2024 Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks." Via Benzinga Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024 July 09, 2024 From Organon & Co. Via Business Wire 3 High-Yield Dividend ETFs to Buy to Generate Passive Income July 06, 2024 These exchange-traded funds should keep the income flowing in regularly. Via The Motley Fool Topics ETFs Value Investing Is Back! 3 Stocks With Strong Fundamentals to Buy Now June 26, 2024 Uncover three top value stocks to buy with robust fundamentals for stable long-term growth amid turbulence. Via InvestorPlace 3 Stocks With Mouthwatering Dividends You Can Buy Right Now June 08, 2024 These stocks offer great dividends and more. Via The Motley Fool European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 May 24, 2024 From Organon & Co. Via Business Wire Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields May 10, 2024 Via Benzinga Organon Announces Pricing of $1.0 Billion Senior Notes Offering May 07, 2024 From Organon & Co. Via Business Wire Organon Announces Proposed $1.0 Billion Senior Notes Offering May 07, 2024 From Organon & Co. Via Business Wire Organon Beats On Q1, Women's Health Leads the Charge May 02, 2024 Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared. Via Benzinga OGN Stock Earnings: Organon Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 OGN stock results show that Organon beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Organon Reports Results for the First Quarter Ended March 31, 2024 May 02, 2024 From Organon & Co. Via Business Wire 7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024 May 01, 2024 While these sleeper stocks to buy don’t attract the spotlight, the lack of attention makes these ideas even more enticing. Via InvestorPlace 3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 May 01, 2024 Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology. Via InvestorPlace Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024 April 08, 2024 From Organon & Co. Via Business Wire Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints April 08, 2024 From Organon & Co. Via Business Wire Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields March 13, 2024 During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... Via Benzinga Turn $500 into a Fortune: 3 Top Stock Picks for March’s Million-Dollar Rally March 07, 2024 Here are three top stock picks for rally have their grip in travel, packaged foods, meats and pharmaceuticals. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.